Nyxoah (NASDAQ:NYXH – Get Free Report) and MSP Recovery (NASDAQ:MSPR – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, profitability, risk and institutional ownership.
Volatility & Risk
Nyxoah has a beta of 1.56, suggesting that its share price is 56% more volatile than the S&P 500. Comparatively, MSP Recovery has a beta of -2.34, suggesting that its share price is 334% less volatile than the S&P 500.
Profitability
This table compares Nyxoah and MSP Recovery’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Nyxoah | -543.21% | -163.73% | -80.24% |
| MSP Recovery | -7,328.48% | -326.80% | -81.27% |
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Nyxoah | $15.33 million | 7.54 | -$101.92 million | ($2.48) | -1.20 |
| MSP Recovery | $9.81 million | 0.04 | -$360.50 million | ($572.83) | 0.00 |
Nyxoah has higher revenue and earnings than MSP Recovery. Nyxoah is trading at a lower price-to-earnings ratio than MSP Recovery, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
3.8% of MSP Recovery shares are held by institutional investors. 17.1% of Nyxoah shares are held by insiders. Comparatively, 50.5% of MSP Recovery shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Nyxoah and MSP Recovery, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Nyxoah | 1 | 1 | 2 | 0 | 2.25 |
| MSP Recovery | 1 | 0 | 0 | 0 | 1.00 |
Nyxoah currently has a consensus target price of $7.67, indicating a potential upside of 157.27%. Given Nyxoah’s stronger consensus rating and higher probable upside, equities analysts plainly believe Nyxoah is more favorable than MSP Recovery.
Summary
Nyxoah beats MSP Recovery on 11 of the 14 factors compared between the two stocks.
About Nyxoah
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
About MSP Recovery
MSP Recovery, Inc. engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by Medicare, Medicaid, and commercial insurance spaces using data and analytics. The company was founded by John H. Ruiz, Frank C. Quesada, and Diana Diaz on July 8, 2014 and is headquartered in Miami, FL.
Receive News & Ratings for Nyxoah Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nyxoah and related companies with MarketBeat.com's FREE daily email newsletter.
